La catena delle opzioni mostra i dati chiave delle opzioni azionarie di Amneal Pharmaceuticals a vari prezzi di esercizio e date di scadenza. I trader utilizzano queste informazioni per analizzare potenziali operazioni e valutare il sentiment del mercato per Amneal Pharmaceuticals..

Amneal Pharmaceuticals (NASDAQ:AMRX) Azioni, Catena delle Opzioni

Amneal Pharmaceuticals

Amneal Pharmaceuticals Inc is a global pharmaceutical company operating primarily in the U.S., India, and Ireland. With three reportable segments; Generics, Specialty, and AvKARE - It develop, manufacture, and distribute a diverse portfolio of essential medicines. The Generics segment focuses on a wide range of dosage forms and delivery systems, contributing significantly to revenues. The Specialty segment promotes proprietary branded pharmaceuticals, particularly targeting the central nervous system and endocrine disorders. The AvKARE segment provides pharmaceuticals and medical products to governmental agencies, specializing in re-packaging and wholesale distribution, with a focus on offering consistent care and pricing to qualified entities.

Amneal Pharmaceuticals, Inc. - Class A Common Stock

Amneal Pharmaceuticals Inc

In a report released today, Balaji Prasad from Barclays maintained a Buy rating on Amneal Pharmaceuticals (AMRX – Research Report), with a price ta...

Amneal Pharmaceuticals (AMRX) Gets a Buy from Barclays

Organon downgraded, Amneal upgraded as J.P. Morgan reviews specialty pharma

Amneal raised to neutral by J.P. Morgan amid improved growth

Analysts have been eager to weigh in on the Healthcare sector with new ratings on Amneal Pharmaceuticals (AMRX – Research Report), Aura Biosciences...

Analysts Offer Insights on Healthcare Companies: Amneal Pharmaceuticals (AMRX), Aura Biosciences Inc (AURA) and Terns Pharmaceuticals (TERN)

An update from Amneal Pharmaceuticals ( ($AMRX) ) is now available. Amneal Pharmaceuticals has joined forces with Metsera, Inc. to develop and supp...

Amneal and Metsera Partner to Target Obesity Market

Amneal and Metsera collaborate to supply obesity and metabolic disease medicines

In a report released today, Les Sulewski from Truist Financial assigned a Buy rating to Amneal Pharmaceuticals (AMRX – Research Report), with a pri...

Amneal Pharmaceuticals (AMRX) Gets a Buy from Truist Financial

Coya Therapeutics Has Several Near-Term Share Price Appreciation Catalysts

Amneal Pharmaceuticals (AMRX) announced that it has received FDA approval of its new drug application, or NDA, for Pyridostigmine Bromide Extended-...

Amneal Pharmaceuticals receives FDA approval of Pyridostigmine Bromide NDA

Amneal gets FDA nod for NDA of its neuromuscular disorder treatment

ABBV

ALEC

AMPH

AMRX

AURA

COYA

PCRX

PRGO

SAVA

SAVAW

TERN

TEVA

VTRS

Press Releases

Amneal Receives U.S. FDA Approval for Potassium Phosphates Injection IV Bags

Amneal Receives U.S. FDA Approval for IPX203 for Treatment of Parkinson's Disease to Be Launched as CREXONT® (Carbidopa and Levodopa) Extended-Release Capsules

Amneal Reports Second Quarter 2024 Financial Results

Amneal Receives U.S. FDA Approval for Propofol Injectable Emulsion Single Dose Vials

Amneal and Shilpa Announce U.S. FDA Approval of BORUZU™, the First Ready-to-Use Version of Bortezomib for subcutaneous administration

Amneal Launches CREXONT® (Carbidopa and Levodopa) Extended-Release Capsules for Treatment of Parkinson's Disease

As Fentanyl Crisis Escalates, Abuse-Deterrent Formulations to Zero in on the Rising Epidemic of Opiate Abuse

Amneal and Metsera Announce Strategic Collaboration to Develop and Supply Portfolio of Next-Generation Medicines for Obesity and Metabolic Diseases

Amneal to Report Third Quarter 2024 Results on November 8, 2024

Amneal Receives U.S. FDA Approval of New Drug Application for Pyridostigmine Bromide Extended-Release Tablets

NTRB

NTRBW

Amphastar Pharmaceuticals, Inc. - Common Stock

Amphastar Pharma

Arvinas

Axsome Therapeutics

Belite Bio, Inc - American Depositary Shares

Belite Bio

Corcept Therapeutics Incorporated - Common Stock

Corcept Therapeutics

Catalent

Elanco Animal Health Incorporated Common Stock

Elanco Animal Health

Edgewise Therapeutics, Inc. - Common Stock

Edgewise Therapeutics

Structure Therapeutics Inc. - American Depositary Shares

Structure Therapeutics

HUTCHMED (China) Limited - American Depositary Shares

HUTCHMED (China)

Harmony Biosciences Holdings, Inc. - Common Stock

Harmony Biosciences

Harrow

Intra-Cellular Therapies Inc. - Common Stock

Intra-Cellular Therapies

Jazz Pharmaceuticals plc - Ordinary Shares

Jazz Pharmaceuticals

Longboard Pharmaceuticals, Inc. - Common Stock

Longboard Pharmaceuticals

Ligand Pharmaceuticals Incorporated - Common Stock

Ligand Pharmaceuticals

Neumora Therapeutics, Inc. - Common Stock

Neumora Therapeutics

Ocular Therapeutix

Organon

Prestige Consumer Healthcare Inc. Common Stock

Prestige Consumer

Dr. Reddy's Laboratories Ltd Common Stock

Dr Reddy's Laboratories

Supernus Pharmaceuticals, Inc. - Common Stock

Supernus Pharmaceuticals

Tarsus Pharmaceuticals, Inc. - Common Stock

Tarsus Pharmaceuticals

Verona Pharma plc - American Depositary Shares

Verona Pharma

Wave Life Sciences Ltd. - Ordinary Shares

Comments

Amneal Pharmaceuticals

Amneal Pharmaceuticals (AMRX) Opzioni

Amneal Pharmaceuticals (NASDAQ:AMRX) Azioni, Catena delle Opzioni

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO